U.S., Jan. 16 -- ClinicalTrials.gov registry received information related to the study (NCT03394703) titled 'Korean Lung Cancer Screening Project' on Dec. 19, 2017.
Brief Summary: Lung cancer is by far the leading cause of cancer death and has a lower relative survival rate than other types of cancer because most lung cancers are detected at an advanced stage when they are first diagnosed.
Recently, a randomized control trial suggests that low-dose computed tomography (LDCT) enables an early stage detection and it has been increasingly accepted as an efficient screening method for high-risk individuals to reduce lung cancer mortality.
In 2011, The National Lung Screening Trial (NLST) in the U.S. has produced results that screening high-r...